Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).

  • FEAnalytics.com
  • FEInvest.net
  • FETransmission.com
  • Investegate.co.uk
  • Trustnet.hk
  • Trustnetoffshore.com
  • Trustnetmiddleeast.com

For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.

WHAT INFORMATION DO WE COLLECT ABOUT YOU?

We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.

COOKIES

In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.

HOW WE USE INFORMATION

We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.

ACCESS TO YOUR INFORMATION AND CORRECTION

We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.

WHERE WE STORE YOUR PERSONAL DATA

The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.

CHANGES TO OUR PRIVACY POLICY

Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.

OTHER WEBSITES

Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.

CONTACT

If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

North Atlantic Smlr (NAS)

  Print      Mail a friend       Annual reports

Wednesday 13 September, 2017

North Atlantic Smlr

Half-year Report

RNS Number : 6377Q
North Atlantic Smlr Co Inv Tst PLC
13 September 2017
 

North Atlantic Smaller Companies Investment Trust plc

Half-Yearly Report for the six months ended 31 July 2017

Registered in England and Wales number 1091347



 

 

objective of the company and financial highlights

The objective of the Company is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 


31 July

2017

(unaudited)

31 January

2017

(audited)

%

Change





Net asset value ("NAV") per 5p Ordinary Share*:




      Basic

 3,180p

2,971p

7.0

      Diluted

 3,177p

2,968p

7.0

      Basic adjusted#

 3,251p

 3,036p

7.1

      Diluted adjusted#

 3,247p

 3,033p

7.1

Mid-market price of the 5p Ordinary Shares

 2,606p

 2,455p

6.2

Discount to diluted net asset value

18.0%

17.3%


Discount to diluted adjusted net asset value

19.7%

19.1%


Standard & Poor's 500 Composite Index†

1,869.3

1,811.7

3.2

Russell 2000 Index†

1,078.4

1,075.1

0.3

US Dollar/Sterling exchange rate

1.3184

1.2581

4.8

Ongoing charges (annualised)

1.0%

1.1%


 

*           Includes current period.

#          Adjusted to reflect Oryx International Growth Fund plc ("Oryx") under the equity method of accounting, which is how the Company previously accounted for its share of Oryx, prior to the adoption of IFRS 10. This is useful to the Shareholder as it shows the NAV based on valuing Oryx at NAV. See note 5.

†          Sterling adjusted.

 



 

chief executive's review

During the six month period to 31 July 2017, the fully diluted net asset value (with Oryx under the equity method of accounting) rose by +7.1% as compared to a rise in the sterling adjusted Standard & Poor's 500 Composite Index of +3.2%.

Income for the period amounted to a profit of £2,592,000 (31 July 2016: loss of £1,530,000). Consistent with past policy, the Directors do not propose to pay a dividend (31 July 2016: nil).

quoted portfolio

Taken as a whole, the quoted portfolio performed well during the six month period. In particular, Bioquell Plc and EKF Diagnostics plc, both rose around 50%. MJ Gleeson Group plc and Oxford Metrics ("OMG"), prior to its sale, also performed well rising by over 20% in each case with Oryx, also up over 12%. The only investment that performed notably badly was Hayward Tyler Group plc, although overall impact on the portfolio was minimal.

Two major new investments were acquired during the period and in particular a £30m holding in Polar Capital Holdings Plc. The investment rationale behind this purchase was that the share price was supported by strong fundamentals but was giving no value to the appointment of Gavin Rochussen as CEO, whose prior experience suggests that he could add significant value to the business over the next few years.

unquoted portfolio

The principal event during the period was the IPO of Ten Entertainment Plc which has added very significant value to the fund over the past two years as the IPO was in excess of 2.5x cost. Performance Chemicals Company was also written up reflecting good operating performance. Industrial Properties Limited is very close to being liquidated at a profit to the 31 January 2017 valuation, although some of this gain will be needed to offset a write down in the continuing liquidation of Hampton Investment Properties Limited.

outlook

The Company continues to be defensively positioned with very significant, albeit reduced, cash balances which obviously adversely impacted performance in the first half of the year. Generally, I continue to believe that equity markets taken as a whole are overvalued. However, a number of our investments have the potential to be harvested at premiums to their current valuation and I look forward to building the asset value over the balance of the year.

 

 

C H B Mills

Chief Executive

13 September 2017



 

chief executive's review (continued)

top ten investments

as at 31 July 2017

 

company


Fair

value

£'000

% of

net assets





US Treasury Bills

US Treasury Stock

65,276

14.2

MJ Gleeson Group plc

UK Listed

55,160

12.0

Oryx International Growth Fund Limited*†

UK Listed

50,632

11.1

Ten Entertainment PLC

UK Listed

31,698

6.9

Polar Capital Holdings plc

UK Unquoted on AIM

29,715

6.5

EKF Diagnostics plc

UK Unquoted on AIM

24,745

5.4

Sportech PLC

UK Listed

14,850

3.2

Sherwood Holdings Limited

UK Unquoted

14,275

3.1

Performance Chemicals Company

US Unquoted

13,781

3.0

Trident Private Equity Fund III LP

UK Unquoted

11,498

2.5



311,630

67.9





 

†          Incorporated in Guernsey.

*           Traded price under IFRS 10.

All investments are valued at fair value.

 

 



 

interim management report

investment objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

material events

The Board do not consider that there were any material events during the period ended 31 July 2017.

material transactions

There were two material transactions during the period; the IPO of Ten Entertainment Plc and the purchase of shares in Polar Capital Holdings Plc. These holdings are valued respectively at £32m and £30m.

risk profile

The principal risks and uncertainties for the remaining six months of the year continue to be as described in the Annual Report for the year ended 31 January 2017 on pages 16 and 17 and pages 64 to 74. The principal risks arising from the Company's financial instruments are market price risk, including currency risk, interest rate risk and other price risk, liquidity risk and credit risk. The Directors review and agree policies with the Manager, Harwood Capital LLP, for managing these risks. The policies have remained substantially unchanged in the six months since the year end.

The Company does not have any significant exposure to credit risk arising from any one individual party. Credit risk is spread across a number of counterparties, each having an immaterial effect on the Company's cash flows, should a default happen. The Company assesses the credit worthiness of its debtors from time to time to ensure that they are neither past due or impaired.

To support its investment in unquoted companies, the Company may periodically agree to guarantee all or part of the borrowings of investee companies. Provision is made for any costs that may be incurred when the Directors consider it likely that the guarantee will crystallise.

The Company's exposure to market price risk comprises mainly movements in the value of the Company's investments. It should be noted that the prices of options tend to be more volatile than the prices of the underlying securities. The Manager assesses the exposure to market risk when making each investment decision and monitors the overall level of market risk on the whole of the investment portfolio on an ongoing basis.

The functional and presentational currency of the Company is Sterling, and therefore, the Company's principal exposure to foreign currency risk comprises investments priced in other currencies, principally US Dollars.

The Company invests in equities and other investments that are realisable.

related party transactions

These are listed in note 10 to the half yearly condensed financial statements.

 

By Order of the Board

 

Peregrine Moncreiffe

Chairman

13 September 2017

responsibility statement

The Directors confirm to the best of their knowledge that:

·      The condensed set of financial statements contained within this half yearly financial report have been prepared in accordance with International Accounting Standard ("IAS") 34 'Interim Financial Reporting' as adopted by the European Union and gives a true and fair view of the assets, liabilities, financial position and profit of the Company; and

·      The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.7R being disclosure of important events that have occurred during the first six months of the financial year, their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the year; and

·      The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.8R being disclosure of related party transactions during the first six months of the financial year, how they have materially affected the financial position of the Company during the period and any changes therein.

The half yearly financial report was approved by the Board on 13 September 2017 and the above responsibility statement was signed on its behalf by:

 

Peregrine Moncreiffe

Chairman

13 September 2017



 

condensed statement of comprehensive income


Six months ended

31 July

2017

(unaudited)

Six months ended

31 July

2016

(unaudited)

Year ended

31 January

2017

(audited)


Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Income

4,999

-

4,999

873

-

873

6,105

-

6,105

Net gains on investments at fair value

-

28,724

28,724

-

8,465

8,465

-

30,069

30,069

Currency exchange (losses)/gains

-

(395)

(395)

-

306

306

-

626

626











total income

4,999

28,329

33,328

873

8,771

9,644

6,105

30,695

36,800











Expenses










Investment management fee (note 10)

(2,190)

(759)

(2,949)

(2,005)

48

(1,957)

(4,009)

48

(3,961)

Other expenses

(213)

-

(213)

(389)

-

(389)

(790)

-

(790)











return before taxation

2,596

27,570

30,166

(1,521)

8,819

7,298

1,306

30,743

32,049











Taxation

(4)

-

(4)

(9)

-

(9)

(11)

-

(11)











return for the period

2,592

27,570

30,162

(1,530)

8,819

7,289

1,295

30,743

32,038











return per ordinary share (note 4)










Basic



209.1p



50.5p



221.9

Diluted



209.1p



50.5p



221.9

 

The total column of the statement is the Statement of Comprehensive Income of the Company prepared in accordance with International Financial Reporting Standards ("IFRS"). The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice ("SORP") issued by the Association of Investment Companies ("AIC").

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.



 

condensed statement of changes in equity


Share

capital

£'000

Share

options

reserve

£'000

Share

premium

account

£'000

Capital

reserve

£'000

Capital

redemption

reserve

£'000

Revenue

reserve

£'000

Total

£'000

six months ended 31 July 2017 (unaudited)








31 January 2017

721

55

1,301

432,444

149

(6,064)

428,606

Total comprehensive income for the period

-

-

-

27,570

-

2,592

30,162









31 July 2017

721

55

1,301

460,014

149

(3,472)

458,768









six months ended 31 July 2016 (unaudited)








31 January 2016*

722

55

1,301

402,094

148

(7,359)

396,961

Total comprehensive income for the period

-

-

-

8,819

-

(1,530)

7,289

Shares purchased for cancellation

-

-

-

(82)

-

-

(82)









31 July 2016

722

55

1,301

410,831

148

(8,889)

404,168









year ended 31 January 2017 (audited)








31 January 2016

722

55

1,301

402,094

148

(7,359)

396,961

Total comprehensive income for the year

-

-

-

30,743

-

1,295

32,038

Shares purchased for cancellation

(1)

-

-

(393)

1

-

(393)









31 January 2017

721

55

1,301

432,444

149

(6,064)

428,606

 

*           Following adoption of IFRS 10 amendments in the year ended 31 January 2017, these brought forward figures are Company only. See note 8b of the Annual Report for the year ended 31 January 2017 for further details.



 

condensed balance sheet


As at

31 July

2017

(unaudited)

£'000

As at

31 July

2016*

(unaudited)

£'000

As at

31 January

2017

(audited)

£'000

non current assets




Investments at fair value through profit or loss

440,394

367,596

414,618






440,394

367,596

414,618

current assets




Trade and other receivables

3,808

2,553

2,516

Cash and cash equivalents

15,815

34,461

11,829






19,623

37,014

14,345





total assets

460,017

404,610

428,963





current liabilities




Trade and other payables

(1,249)

(442)

(357)





total liabilities

(1,249)

(442)

(357)





total assets less current liabilities

458,768

404,168

428,606





net assets

458,768

404,168

428,606





represented by:




Share capital

721

722

721

Capital redemption reserve

55

55

55

Share premium account

1,301

1,301

1,301

Capital reserve

460,014

410,831

432,444

Share options reserve

149

148

149

Revenue reserve

(3,472)

(8,889)

(6,064)





total equity attributable to equity holders of the company

458,768

404,168

428,606





net asset value per ordinary share (note 5):




Basic

3,180p

2,799p

2,971p

Diluted

3,177p

2,796p

2,968p









*           Following adoption of IFRS 10 amendments in the year ended 31 January 2017, these figures are Company only. See note 8b of the Annual Report for the year ended 31 January 2017 for further details.

condensed cash flow statement


Six months

ended

31 July

2017

(unaudited)

£'000

Six months

ended

31 July

2016

(unaudited)

£'000

Year ended

31 January

2017

(audited)

£'000





cash flows from operating activities




Investment income received

2,902

950

2,112

Other income

192

38

2,438

Investment Manager's fees paid

(2,208)

(3,986)

(6,058)

Other cash payments

(363)

(1,045)

(821)





cash generated/(expended) from operations (note 7)

523

(4,043)

(2,329)

Taxation paid

(4)

(9)

(11)





net cash inflow/(outflow) from operating activities

519

(4,052)

(2,340)





cash flows from investing activities




Purchases of investments

(244,178)

(223,729)

(446,923)

Sales of investments

247,782

231,382

430,274





net cash inflow/(outflow) from investing activities

3,604

7,653

(16,649)





cash flows from financing activities




Repurchase of Ordinary Shares for cancellation

-

(82)

(393)





net cash outflow from financing activities

-

(82)

(393)





increase/(decrease) in cash and cash equivalents for the period

4,123

3,519

(19,382)

cash and cash equivalents at the start of the period

11,829

30,839

30,839

Revaluation of foreign currency balances

(137)

103

372





cash and cash equivalents at the end of the period

15,815

34,461

11,829

 

 



 

notes

1. a) general information

North Atlantic Smaller Companies Investment Trust plc ("NASCIT") is a Company incorporated and domiciled in Great Britain and registered in England and Wales.

The Company operates as an investment trust company within the meaning of Section 833 of the Companies Act 2006 and has made a successful application under Regulation 5 of the Investment Trust (Approved Company) (Tax) Regulations 2011 for investment trust status to apply to all accounting periods starting on or after 1 February 2013. The Company is managed in such a way to ensure that it continues to meet the eligibility conditions contained in Section 1158 of the Corporation Tax Act 2010 and the ongoing requirements outlined in Chapter 3 of Part 2 of the regulations.

b) basis of preparation

The condensed interim financial statements for the six months ended 31 July 2017 have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all financial information required for full annual financial statements and have been prepared using the accounting policies adopted in the audited financial statements for the year ended 31 January 2017. Those financial statements were prepared in accordance with IFRS and with the SORP for Investment Companies and Venture Capital Trusts issued by the AIC in November 2014 and updated in January 2017 with consequential amendments.

The condensed interim financial information includes the financial statements of the Company, for the six months ended 31 July 2017.

c) significant accounting policies

The accounting policies applied are consistent with those of the Annual Financial Report for the year ended 31 January 2017. Since the year end no new standards have been adopted.

d) segmental reporting

The Directors are of the opinion that the Company is engaged in a single segment of business, being investment business. The Company invests in smaller companies principally based in countries bordering the North Atlantic Ocean.

e) going concern

The Company has adequate financial resources and no significant investment commitments and as a consequence, the Directors believe that the Company is well placed to manage its business risks successfully. After making appropriate enquiries, the Directors have a reasonable expectation that the Company has adequate available financial resources to continue in operational existence for the foreseeable future and accordingly have concluded that it is appropriate to continue to adopt the going concern basis in preparing this half yearly financial report.

2. investment management and performance fees

A Performance Fee is only payable if the investment portfolio, including Oryx at the adjusted price, outperforms the Sterling adjusted Standard & Poor's 500 Composite Index at the end of each financial year and is limited to a maximum payment of 0.5% of Shareholders' Funds, and is allocated 100% to capital.

In accordance with the SORP for investment trust companies, an amount would be included in these financial statements for the Performance Fee that could be payable based on investment performance to 31 July 2017.

At that date, a Performance Fee of £759,000 including irrecoverable VAT has been accrued for in the accounts (31 July 2016: £nil; 31 January 2017: £nil).



 

notes (continued)

3. taxation

The Company has an effective tax rate of 0%. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income and thus there is no charge for corporation tax.

During the half year to 31 July 2017, the Company recognised a total charge of £4,000 (half year to 31 July 2016: £9,000, year ended 31 January 2017: £11,000), representing irrecoverable withholding tax paid on overseas investment income.

4. return per ordinary share


Revenue

Capital

Total


Net

Ordinary

Per

Net

Ordinary

Per

Net

Ordinary

Per

 


return

Shares

Share

return

Shares

Share

return

Shares

Share

 

six months ended 31 July 2017 (unaudited)










 

Basic return per share

2,592

14,425,620

18.0

27,570

14,425,620

191.1

30,162

14,425,620

209.1

 

Share options*

-

2,846


-

2,846


-

2,846


 











 

Diluted return per share

2,592

14,428,466

18.0

27,570

14,428,466

191.1

30,162

14,428,466

209.1

 











 

six months ended 31 July 2016 (unaudited)










 

Basic return per share

(1,530)

14,440,412

(10.6)

8,819

14,440,412

61.1

7,289

14,440,412

50.5

 

Share options*

-

-


-

-


-

-


 











 

Diluted return per share

(1,530)

14,440,412

(10.6)

8,819

14,440,412

61.1

7,289

14,440,412

50.5

 











 

year ended 31 January 2017 (audited)










 

Basic return per share

1,295

14,436,637

9.0

30,743

14,436,637

212.9

32,038

14,436,637

221.9

 

Share options*

-

-


-

-


-

-


 











 

Diluted return per share

1,295

14,436,637

9.0

30,743

14,436,637

212.9

32,038

14,436,637

221.9

 

 

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

*           Excess of total number of potential shares on Option Conversion over the number that could be issued at the average market price, as calculated in accordance with IAS 33: Earnings per share.

5. net asset value per ordinary share

The basic net asset value per Ordinary Share is based on net assets of £458,768,000 (31 July 2016: £404,168,000; 31 January 2017: £428,606,000) and on 14,425,620 Ordinary Shares (31 July 2016: 14,438,520; 31 January 2017: 14,425,620) being the number of Ordinary Shares in issue at the period end.

The diluted net asset value per Ordinary Share is calculated on the assumption that all 30,000 (31 July 2016: 30,000; 31 January 2017: 30,000) Share Options in-the-money were exercised at the prevailing exercise prices, giving a total of 14,455,620 issued Ordinary Shares (31 July 2016: 14,468,520; 31 January 2017: 14,455,620).

During the period, there was no change to the Ordinary Shares in issue.



 

notes (continued)

5. net asset value per ordinary share (continued)

 

adjustment for Oryx

The Company has also reported an adjusted net asset value per share using equity accounting, in accordance with its previous method of valuing its investment in Oryx. The Company has chosen to report this net asset value per share to show the difference derived if equity accounting were to be used. Equity accounting permits the use of net asset value pricing for listed assets which in the case of Oryx is higher than its fair value.

The values of Oryx, as at each period end, are as follows:


31 July 2017

31 July 2016

31 January 2017


(unaudited)

(unaudited)

(audited)


£'000

£'000

£'000





Oryx at Fair value (traded price) using IFRS 10

50,632

42,638

45,303

Oryx value using Equity Accounting

60,830

51,378

54,647

Increase in net assets using Equity Accounting

10,198

8,740

9,344

 


31 July 2017

31 July 2016

31 January 2017


(unaudited)

(unaudited)

(audited)





Net asset value per Share




- Basic

3,180p

2,799p

2,971p

- Diluted

3,177p

2,796p

2,968p

 

Net asset value per Share adjusted




- Basic

3,251p

2,860p

3,036p

- Diluted

3,247p

2,857p

3,033p

 

6. share based remuneration

As at 31 July 2017 and as at the date of this report, there were a total of 30,000 options in issue with an estimated fair value of £0.4m (31 July 2016: 30,000; 31 January 2017: 30,000). 10,000 options are under the 2011 options scheme and 20,000 options are under the 2012 option scheme.

7. reconciliation of total return from ordinary activities before taxation to cash generated/(expended) from operations


Six months

ended

31 July

2017

(unaudited)

£'000

Six months

ended

31 July

2016

(unaudited)

£'000

Year ended

31 January

2017

(audited)

£'000





Return before taxation

30,166

7,298

32,049

Gains on investments

(28,329)

(8,771)

(30,695)

Dividends and interest reinvested

(870)

-

(647)

Subsidiary dealing gains

(89)

-

-

Increase in debtors and accrued income

(1,247)

(258)

(639)

Increase/(decrease) in creditors and accruals

892

(2,312)

(2,397)





Cash generated/(expended) from operations

523

(4,043)

(2,329)

 



 

notes (continued)

8. investments

financial assets at fair value through profit or loss

The Company adopted the amendment to IFRS 13, effective 1 January 2009. This requires the Company to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy consists of the following three levels:

·      Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.

An active market is a market in which transactions for the asset or liability occur with sufficient frequency and volume on an ongoing basis such that quoted prices reflect prices at which an orderly transaction would take place between market participants at the measurement date. Quoted prices provided by external pricing services, brokers and vendors are included in Level 1, if they reflect actual and regularly occurring market transactions on an arms length basis.

·      Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices).

 

·      Level 3 - Inputs for the asset or liability that are not based on observable market data (unobservable inputs).

The Company's main unobservable inputs are earnings multiples, recent transactions and net asset basis. The market value would be sensitive to movements in these unobservable inputs. Movements in these inputs, individually or in aggregate could have a significant effect on the market value. The effect of such a change or a reasonable possible alternative would be difficult to quantify as such data is not available.

The level in the fair value hierarchy within which the fair value measurement is categorised in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgement, considering factors specific to the asset or liability.

The determination of what constitutes 'observable' requires significant judgement by the Company. The Company considers observable data from investments actively traded in organised financial markets, fair value is generally determined by reference to Stock Exchange quoted market bid prices at the close of business on the Balance Sheet date, without adjustment for transaction costs necessary to realise the asset.

The table below sets out fair value measurements of financial assets in accordance with the IFRS 13 fair value hierarchy system:

six months ended 31 July 2017 (unaudited)


Total

£'000

Level 1

£'000

Level 2

£'000

Level 3

£'000






Equity investments

340,746

291,445

-

49,301

Fixed interest investments

109,846

65,276

-

44,570






Total

450,592

356,721

-

93,871



 

notes (continued)

8. investments (continued)

 

six months ended 31 July 2016 (unaudited)


Total

£'000

Level 1

£'000

Level 2

£'000

Level 3

£'000






Equity investments

235,045

166,624

-

68,421

Fixed interest investments

132,551

101,243

-

31,308






Total

367,596

267,867

-

99,729

 

year ended 31 January 2017 (audited)


Total

£'000

Level 1

£'000

Level 2

£'000

Level 3

£'000






Equity investments

238,464

168,482

3,720

66,262

Fixed interest investments

176,154

116,747

-

59,407






Total

414,618

285,229

3,720

125,669

 

level 3 financial assets at fair value through profit or loss

A reconciliation of fair value measurements in Level 3 is set out below:

at 31 July 2017


Total

£'000

Equity

investments

£'000

Fixed interest

investments

£'000





Opening balance at 31 January 2017

125,669

66,262

59,407





Purchases

11,109

5,239

5,870

Sales

(25,642)

(13,440)

(12,202)





Transfers between levels

(549)

6,711

(7,260)





Total (losses)/gains included in gains on investments in the statement of comprehensive income:




on assets sold

(4,082)

(4,231)

149

on assets held at the end of the period

(12,634)

(11,240)

(1,394)





Closing balance

93,871

49,301

44,570

 



 

notes (continued)

8. investments (continued)

 

unquoted at directors' estimate of fair value

Unquoted investments are valued in accordance with the International Private Equity and Venture Capital Valuation ("IPEV") Guidelines. Their valuation incorporates all factors that market participants would consider in setting a price. The primary valuation techniques employed to value the unquoted investments are earnings multiples, recent transactions and the net asset basis. Valuations in local currency are translated into Sterling at the exchange rate ruling on the Balance Sheet date.

Included within the Statement of Comprehensive Income as at 31 July 2017, is a loss of £13,588,000 relative to the movement in the fair value of the unquoted investments valued using IPEV valuation techniques.

the valuation techniques applied are based on the following assumptions:

Unquoted investments are usually valued by reference to the valuation multiples of similar listed companies, transactions in the entity itself, or from transactions of similar businesses. Where appropriate, discounts are then applied to those comparable multiples to reflect differences in size and liquidity. These enterprise values are then adjusted for net debt to arrive at an equity valuation. Where companies are in compliance with the loan note terms these loans are generally held at par plus accrued interest (where applicable) unless the enterprise value suggests that the debt cannot be recovered, or where this is not deemed to be equal to fair value.

9. principal risk profile

The principal risks which the Company faces include exposure to:

(i)         market price risk, including currency risk, interest rate risk and other price risk;

(ii)         liquidity risk; and

(iii)        credit risk.

Further details of the Company's management of these risks and exposure to them is set out in Note 14 of the Company's Annual Report for the year ended 31 January 2017, as issued on 19 May 2017. There have been no changes to the management of or exposure to these risks since that date.



 

notes (continued)

10. related party transactions

There have been no changes to the related party arrangements or transactions as reported in the Statutory Annual Financial Report for the year ended 31 January 2017.

The Manager, Harwood Capital LLP, is regarded as a related party of the Company. The amounts payable to the Manager and Growth Financial Services Limited in respect of investment management for the six months to 31 July 2017 are as follows:


Six months

ended

31 July

2017

(unaudited)

£'000

Six months

ended

31 July

2016

(unaudited)

£'000

Year ended

31 January

2017

(audited)

£'000

Annual fee

2,190

2,005

4,009

Performance fee

745

-

-

Irrecoverable VAT thereon

14

(48)*

(48)*






2,949

1,957

3,961

 

* Adjustment to 2016 VAT based on actual amount of VAT recovered in VAT return.

Shareholders should also note any payments made under share based remuneration as disclosed in note 6 to these financial statements.

11. financial information

The financial information contained in this half yearly report does not constitute full Statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information for the periods ended 31 July 2017 and 31 July 2016 is not a financial year and has not been audited. The information for the financial year ended 31 January 2017 has been extracted from the latest published Financial Statements, which have been delivered to the Registrar of Companies. The Report of the Auditors on those Financial Statements contained no qualification or statement under Section 498 of the Companies Act 2006.



 

shareholder information

financial calendar

Announcement of results and annual report          May

Annual General Meeting                                     June

Half Yearly figures announced                             September

Half Yearly Report posted                                   September

share price

The Company's mid-market share price is quoted daily in the Financial Times appearing under "Investment Companies".

It also appears on:

SEAQ Ordinary Shares:                                     NAS

Trustnet:                                                           www.trustnet.com

net asset value

The latest net asset value of the Company can be found on the Harwood Capital LLP website:

www.harwoodcapital.co.uk

share dealing

Investors wishing to purchase more Ordinary Shares or dispose of all or part of their holding may do so through a stockbroker. Many banks also offer this service.

The Company's registrars are Capita Asset Services. In the event of any queries regarding your holding of shares, please contact the registrars on: 0871 664 0300, or by email on [email protected]

Changes of name or address must be notified to the registrars in writing at:

Capita Asset Services

The Registry

34 Beckenham Road

Beckenham

Kent BR3 4TU



 

shareholder information (continued)

Directors

Peregrine Moncreiffe (Chairman)

Christopher Mills (Chief Executive)

Kristian Siem

Lord Howard of Rising

Enrique Foster Gittes

Manager

Harwood Capital LLP

(Authorised and regulated by the Financial Conduct Authority)

6 Stratton Street

Mayfair

London W1J 8LD

Telephone: 020 7640 3200

Financial Adviser and Stockbroker

Winterflood Investment Trusts

The Atrium Building

Cannon Bridge

25 Dowgate Hill

London EC4R 2GA

Registered Office

6 Stratton Street

Mayfair

London W1J 8LD

Telephone: 020 7640 3200

Registrars

Capita Asset Services

34 Beckenham Road

Beckenham

Kent BR3 4TU

Auditors

KPMG LLP

15 Canada Square

London E14 5GL

Company Secretary

Derringtons Limited

Hyde Park House

5 Manfred Road

London SW15 2RS


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BXLFFDKFBBBD

a d v e r t i s e m e n t